Advanced Enzyme Technologies Fact Sheet, Advanced Enzyme Technologies Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Advanced Enzyme Technologies Fact Sheet    (AETL)


RSVP REQUIRED: Your Invitation to Attend the Super Smallcaps Summit


Here is the latest financial fact sheet of Advanced Enzyme Technologies. For more details, see the Advanced Enzyme Technologies quarterly results and Advanced Enzyme Technologies share price and chart. For a sector overview, read our pharmaceuticals sector report.

ADVANCED ENZYME TECHNOLOGIES Price History

Price Rs 387.3
Mkt Cap Rs m 43,272
Vol '000 25.7
P/E X 27.6
P/CF X 24.1
EPS (TTM) Rs 14.0
% ch % -0.9
No. of shares m 111.73
% ch week % -1.6
% ch 1-mth % 5.2
% ch 12-mth % 74.2
52 week H/L Rs 503.0/219.1
(As on Sep 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ADVANCED ENZYME TECHNOLOGIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ADVANCED ENZYME TECHNOLOGIES EQUITY SHARE DATA
High Rs2,3772,225263225417 
Low Rs1,16120714591129 
Sales per share (Unadj.) Rs141.034.637.639.844.9 
Earnings per share (Unadj.) Rs41.68.410.411.913.6 
Diluted earnings per shareRs8.38.410.411.913.6 
Cash flow per share (Unadj.) Rs47.310.012.314.216.1 
Dividends per share (Unadj.) Rs0.400.500.600.600.60 
Adj. dividends per shareRs0.080.500.600.600.60 
Avg Dividend yield %000.30.40.2 
Book value per share (Unadj.) Rs207.749.860.574.986.6 
Adj. book value per shareRs41.549.860.474.886.6 
Shares outstanding (eoy) m22.33111.63111.65111.68111.73 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x12.535.15.44.06.1 
Avg P/E ratio x42.5145.119.713.320.1 
P/CF ratio (eoy) x37.4121.416.711.117.0 
Price / Book Value ratio x8.524.43.42.13.1 
Dividend payout %1.06.05.85.04.4 
Avg Mkt Cap Rs m39,495135,74222,81817,64830,491 
No. of employees `000NANANANANA 
Total wages/salary Rs m507686780802871 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ADVANCED ENZYME TECHNOLOGIES INCOME DATA
Net Sales Rs m3,1493,8634,1964,4405,018 
Other income Rs m2828575988 
Total revenues Rs m3,1773,8914,2534,4995,107 
Gross profit Rs m1,5151,6351,8262,0312,325 
Depreciation Rs m128183211258284 
Interest Rs m4491524126 
Profit before tax Rs m1,3711,3901,6201,7922,104 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m441454461461589 
Profit after tax Rs m9299361,1591,3301,515 
Gross profit margin %48.142.343.545.846.3 
Effective tax rate %32.232.728.425.728.0 
Net profit margin %29.524.227.630.030.2 
ADVANCED ENZYME TECHNOLOGIES BALANCE SHEET DATA
Current assets Rs m1,4302,1072,8213,7565,161 
Current liabilities Rs m653988651595676 
Net working cap to sales %24.729.051.771.289.4 
Current ratio x2.22.14.36.37.6 
Inventory Days Days129107120102 
Debtors Days Days5855516163 
Net fixed assets Rs m4,3975,1675,2315,9566,297 
Share capital Rs m223223223223223 
"Free" reserves Rs m4,4145,3416,5308,1379,457 
Net worth Rs m4,6375,5646,7538,3609,680 
Long term debt Rs m195198704299 
Total assets Rs m5,8277,2748,0529,71211,458 
Interest coverage x31.916.332.144.983.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.50.50.50.4 
Return on assets %16.714.115.014.113.4 
Return on equity %20.016.817.215.915.6 
Return on capital %29.325.724.521.821.8 
Exports to sales %19.614.415.916.40 
Imports to sales %6.06.36.86.10 
Exports (fob) Rs m6185586697290 
Imports (cif) Rs m1902422862690 
Fx inflow Rs m6275586697290 
Fx outflow Rs m2192422862690 
Net fx Rs m4083153834590 
ADVANCED ENZYME TECHNOLOGIES CASH FLOW
From Operations Rs m 1,074 1,160 1,286 1,409 1,629 
From Investments Rs m -603 -782 -1,247 -445 -260 
From Financial Activity Rs m -653 -21 -431 -386 -263 
Net Cashflow Rs m -178 536 -381 596 1,093 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 52.3%
Institution 24.9%
Non-Institution 22.8%
Total 100.0%
Free Float 47.7%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Sun- Magnetica A Wing, 5th Floor Near L I C Service Road, Louiswadi, Thane - 400604
E-MAIL info@advancedenzymes.com WEB www.advancedenzymes.com
TEL 022 41703200 FAX 022-25835159
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1989 BSE CODE: 540025 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   ZENITH HEALTH  TRANS ASIA CORP  PANCHSHEEL ORG  ARTEMIS MEDICARE SERVICES  THYROCARE TECHNOLOGIES  

Compare ADVANCED ENZYME TECHNOLOGIES With:   ZENITH HEALTH  TRANS ASIA CORP  PANCHSHEEL ORG  ARTEMIS MEDICARE SERVICES  THYROCARE TECHNOLOGIES  




Today's Market

Sensex Skyrockets 958 Points to End at New Peak; Banking & Realty Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

ADVANCED ENZYME TECHNOLOGIES Announces Quarterly Results (1QFY22); Net Profit Up 14.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ADVANCED ENZYME TECHNOLOGIES has posted a net profit of Rs 399 m (up 14.5% YoY). Sales on the other hand came in at Rs 1 bn (up 24.0% YoY). Read on for a complete analysis of ADVANCED ENZYME TECHNOLOGIES's quarterly results.

ADVANCED ENZYME TECHNOLOGIES Announces Quarterly Results (4QFY21); Net Profit Up 3.4% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, ADVANCED ENZYME TECHNOLOGIES has posted a net profit of Rs 338 m (up 3.4% YoY). Sales on the other hand came in at Rs 1 bn (up 20.8% YoY). Read on for a complete analysis of ADVANCED ENZYME TECHNOLOGIES's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

India's Most Trusted Corporate Group is... (Views On News)

Sep 11, 2021

We conducted a poll of 17 of the most popular corporate groups in India. With an overwhelming response from 5,274 participants, here is what we found.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ADVANCED ENZYME TECHNOLOGIES

  • Track your investment in ADVANCED ENZYME TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES - SANJIVANI PA COMPARISON

COMPARE ADVANCED ENZYME TECHNOLOGIES WITH

MARKET STATS